Marco Braggion

Marco Braggion

Auto-generated profile, based on publicly available information

Marco Braggion

Epidemiological Department, Azienda Zero, Veneto Region, Italy

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in International Archives of Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
SASimone Accordini
Simone Accordini
ACAngelo Guido Corsico
Angelo Guido Corsico
MBMarco Braggion
Marco Braggion
MGMargaret W Gerbase
Margaret W Gerbase
DGDavid Gislason
David Gislason
RMRoberto De Marco
Roberto De Marco
Background: This study is aimed at providing a real-world evaluation of the economic cost of persistent asthma among European adults according to the degree of disease control [as defined by the 2006 Global Initiative for Asthma (GINA) guidelines]. Methods: A prevalence-based cost-of-illness study was carried out on 462 patients aged 30–54 years with persistent asthma (according to the 2002 GINA definition), who were identified in general population samples from 11 European countries and examined in clinical settings in the European Community Respiratory Health Survey II between 1999 and 2002. The cost estimates were computed from the societal perspective following the bottom-up approach on the basis of rates, wages and prices in 2004 (obtained at the national level from official sources), and were then converted to the 2010 values. Results: The mean total cost per patient was EUR 1,583 and was largely driven by indirect costs (i.e. lost working days and days with limited, not work-related activities 62.5%). The expected total cost in the population aged 30–54 years of the 11 European countries was EUR 4.3 billion (EUR 19.3 billion when extended to the whole European population aged from 15 to 64 years). The mean total cost per patient ranged from EUR 509 (controlled asthma) to EUR 2,281 (uncontrolled disease). Chronic cough or phlegm and having a high BMI significantly increased the individual total cost. Conclusions: Among European adults, the cost of persistent asthma drastically increases as disease control decreases. Therefore, substantial cost savings could be obtained through the proper management of adult patients in Europe.

17 October 2011 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
RMR. de Marco
R. de Marco
VCV. Cappa
V. Cappa
SAS. Accordini
S. Accordini
MRMarta Rava
Marta Rava
LAL. Antonicelli
L. Antonicelli
GVGiuseppe Verlato
Giuseppe Verlato
The prevalence of asthma increased worldwide until the 1990s, but since then there has been no clear temporal pattern.The present study aimed to assess time trends in the prevalence of current asthma, asthma-like symptoms and allergic rhinitis in Italian adults from 1990 to 2010.The same screening questionnaire was administered by mail or phone to random samples of the general population (age 20–44 yrs) in Italy, in the frame of three multicentre studies: the European Community Respiratory Health Survey (ECRHS) (1991–1993; n=6,031); the Italian Study on Asthma in Young Adults (ISAYA) (1998–2000; n=18,873); and the Gene Environment Interactions in Respiratory Diseases (GEIRD) study (2007–2010; n=10,494). Time trends in prevalence were estimated using Poisson regression models in the centres that repeated the survey at different points in time.From 1991 to 2010, the median prevalence of current asthma, wheezing and allergic rhinitis increased from 4.1% to 6.6%, from 10.1% to 13.9% and from 16.8% to 25.8%, respectively. The prevalence of current asthma was stable during the 1990s and increased (relative risk 1.38, 95% CI 1.19–1.59) from 1998–2000 to 2007–2010, mainly in subjects who did not report allergic rhinitis. The prevalence of allergic rhinitis has increased continuously since 1991.The asthma epidemic is not over in Italy. During the past 20 yrs, asthma prevalence has increased by 38%, in parallel with a similar increase in asthma-like symptoms and allergic rhinitis.

1 October 2011 in The Journal of Bone and Joint Surgery. British volume
Verified
Journal Article
Closed access
PDF file
DRDario Regis
Dario Regis
ASA. Sandri
A. Sandri
IBI. Bonetti
I. Bonetti
MBM. Braggion
M. Braggion
PBP. Bartolozzi
P. Bartolozzi
Revision after failed femoral components may be technically demanding due to loss of peri-prosthetic bone. This retrospective study evaluated the long-term results of femoral revision using the cementless Wagner Self-Locking stem. Between 1992 and 1998, 68 consecutive hips in 66 patients underwent femoral revision using this implant. A total of 25 patients died from unrelated causes without further revision; the remaining 41 hips in 41 patients (12 men and 29 women) with a mean age of 61 years (29 to 80) were reviewed at a mean follow-up of 13.9 years (10.4 to 15.8). A transfemoral approach was used in 32 hips. A total of five stems required further revision because of infection in two, progressive subsidence in two and recurrent dislocation in one. Four hips had dislocated and eight stems had subsided ≥ 10 mm. The mean Harris hip score improved from 33 points pre-operatively to 75 points at final follow-up (p < 0.001). In all, 33 stems (91.7%) showed radiological signs of stable bone fixation. The cumulative survival rates at 15.8 years with femoral revision for any reason and for stem failure as the endpoints were 92.0% (95% confidence interval (CI) 86.0% to 98.4%) and 96.6% (95% CI 92.2% to 100%), respectively. The survivorship with revision and ≥ 10 mm migration of the stem as the endpoint was 83.6% (95% CI 76.6% to 91.4%). This study shows quite good survival and moderate clinical outcome when using a monoblock tapered titanium stem for supporting the regeneration of bone in complex revision hip surgery.

14 April 2010 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
PGPaolo Girardi
Paolo Girardi
MBMarco Braggion
Marco Braggion
GSGiuseppe Sacco
Giuseppe Sacco
FGFranco De Giorgi
Franco De Giorgi
SCStefano Corra
Stefano Corra

1 September 2015 in Science of The Total Environment
Verified
Journal Article
Closed access
Alessandro MarconAlessandro Marcon
Alessandro Marcon
GNGiang Nguyen
Giang Nguyen
MRMarta Rava
Marta Rava
MBMarco Braggion
Marco Braggion
MGMario Grassi
Mario Grassi
MZMaria Elisabetta Zanolin
Maria Elisabetta Zanolin

1 January 2020 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
MBMarco Braggion
Marco Braggion
MPMichele Pellizzari
Michele Pellizzari
CBCristina Basso
Cristina Basso
PGPaolo Girardi
Paolo Girardi
VZValentina Zabeo
Valentina Zabeo
UFUgo Fedeli
Ugo Fedeli